MORGAN STANLEY PLC/PUT/MEDTRONIC/70/0.1/20.12.24 Share Price

Warrant

DE000MB8M1Q9

Market Closed - Börse Stuttgart 17:05:25 26/06/2024 BST
0.138 EUR +3.76% Intraday chart for MORGAN STANLEY PLC/PUT/MEDTRONIC/70/0.1/20.12.24
Current month-1.43%
1 month+12.20%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
26/06/24 0.138 +3.76%
25/06/24 0.133 +9.02%
24/06/24 0.122 -9.63%
21/06/24 0.135 -3.57%
20/06/24 0.14 -1.41%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 05:05 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB8M1Q
ISINDE000MB8M1Q9
Date issued 12/07/2023
Strike 70 $
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.73
Lowest since issue 0.085
Delta-0.18x
Omega 9.837
Premium14.38x
Gearing54.92x
Moneyness 0.8745
Difference Strike -10.05 $
Difference Strike %-14.36%
Spread 0.003
Spread %2.17%
Theoretical value 0.1365
Implied Volatility 24.74 %
Total Loss Probability 77.16 %
Intrinsic value 0.000000
Present value 0.1365
Break even 68.54 €
Theta-0.01x
Vega0.01x
Rho-0.01x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.05 USD
Average target price
94.02 USD
Spread / Average Target
+17.46%
Consensus